NICE public health guidance
Issued: February 2008 (last modified: November 2013)
PH10

Smoking cessation services

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ph10

Appendix E: supporting documents

Supporting documents are available from the NICE website. These include the following.

  • Reviews of effectiveness

    • Review 1: 'Rapid review of non NHS treatments of smoking cessation'

    • Review 2: 'The effectiveness of National Health Service intensive treatments for smoking cessation in England'

    • Review 3: 'Workplace policies for smoking cessation'

    • Review 4: 'A review of the effectiveness of mass media interventions which both encourage quit attempts and reinforce current and recent attempts to quit smoking'

    • Review 5: 'The impact of quitlines on smoking cessation'

    • Expert paper: 'Mass media interventions to stimulate and promote smoking cessation'.

  • Economic evaluations

    • 'A rapid review of the cost effectiveness of non-National Health Service treatments for smoking cessation in England'

    • 'A rapid review of the cost effectiveness of National Health Service treatments for smoking cessation in England'

    • 'A rapid review of the cost effectiveness of workplace policies for smoking cessation in England'

    • 'A rapid review of: the cost effectiveness of mass media interventions for smoking cessation in England'.

  • Economic analyses

    • 'Cost-effectiveness of interventions for smoking cessation'

    • 'Cost-effectiveness of interventions for smoking cessation: mass media'

    • 'Cost-impact analysis of interventions of interventions for smoking cessation aimed at pregnant women'.

  • Reviews for the update of technology appraisal guidance 39

    • 'Cut down to quit with nicotine replacement therapies (NRT) in smoking cessation: systematic review of effectiveness and economic analysis'

    • 'Clinical and cost-effectiveness of nicotine replacement therapy for new licensed indications and combination therapy: a summary of best evidence'.

For information on how NICE public health guidance is developed, see: